Coronavirus Files: FDA supports spring booster; new drug authorized for severe COVID
After weeks of rumors about spring boosters, the FDA is expected to approve a second round of omicron-specific shots for people who are 65 and older or immunocompromised, report Laurie McGinley and Lena H. Sun at The Washington Post.
FDA forces unproven premature birth drug Makena off market
The Food and Drug Administration on Thursday ordered the immediate market withdrawal of a drug intended to prevent premature births, which has remained available for years despite data showing it doesn’t help pregnant women.
Novel treatment shows promise against rare cancer in kids
A novel treatment using supercharged immune cells appears to work against tumors in children with a rare kind of cancer, researchers reported Wednesday.
Babesiosis: A Lesser-Known Tick-Borne Disease Rises in the Northeast
Lyme disease isn’t the only tick-borne disease those of us in the Northeast and Midwest should worry about this summer. A recent report from the CDC found a significant increase in the Northeast of cases of babesiosis (ba-BEE-see-OH-sis), a disease caused by parasites transmitted by the blacklegged tick.
Biden-Harris Administration Celebrates the Affordable Care Act’s 13th Anniversary and Highlights Record-Breaking Coverage
The Biden-Harris Administration celebrated the 13th anniversary of the Affordable Care Act (ACA) by highlighting record-breaking enrollment numbers during the 2023 Marketplace Open Enrollment Period and lower health care costs because of President Biden’s American Rescue Plan (ARP) and Inflation Reduction Act (IRA).
